Ronald E. Blaylock, a director at Pfizer Inc. (NYSE:PFE), purchased 19,457 shares of the company's common stock. The ...

Shareholders are set to convene in April at Pfizer’s annual meeting to vote on the company’s director seats for the year. A Starboard-backed director—or two—would have given the investor ...

The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks so that physicians would prescribe a specific migraine drug to patients ...

"We want people to think of Pfizer in a different way," says Brenna Robinson, director, Global Reputation, Digital, Content & Media Strategy at Pfizer. "If people view us differently and interact ...

Pfizer announced Jeffrey Legos, PhD, MBA as its new chief oncology officer. Bluejay Therapeutics announced Mary Cromwell, PhD, has joined its leadership team as SVP and head of technical operations.